Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Ovid Therapeutics Inc (OVID)

128 + Investors. Track Smart Money conviction in OVID. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +27
Streak
4Q ▲
Buyers last Q
63%

Smart Money Signals — OVID

Based on 129 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q
For 4 consecutive quarters, more hedge funds added OVID than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
129 hedge funds hold OVID right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +90% more funds vs a year ago

fund count last 6Q
+61 new funds entered over the past year (+90% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 63% buying

80 buying47 selling
Last quarter: 80 funds were net buyers (46 opened a brand new position + 34 added to an existing one). Only 47 were sellers (28 trimmed + 19 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+18 vs last Q)

new funds entering per quarter
Funds opening a new OVID position: 26 → 20 → 28 → 46. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

45% of holders stayed for 2+ years

■ 45% conviction (2yr+) ■ 21% medium ■ 34% new
58 out of 129 hedge funds have held OVID for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +69% but shares only +39% — price-driven

Value
+69%
Shares
+39%
Last quarter: the total dollar value of institutional holdings rose +69%, but actual share count only changed +39%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

17 → 26 → 20 → 28 → 46 new funds/Q
New funds entering each quarter: 26 → 20 → 28 → 46. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 56% veterans vs 35% newcomers

■ 56% veterans ■ 9% 1-2yr ■ 35% new
Entry-cohort mix of 132 holders: 74 (56%) are 2+ year veterans, 12 entered 1–2 years ago, and 46 (35%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 20% AUM from major funds

20% from top-100 AUM funds
37 of 128 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.8
out of 10
Moderate Exit Risk
Exit risk score 4.8/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — OVID

In 2026 Q2, 80 hedge funds were net buyers of OVID (46 opened a new position, 34 added to an existing one), while 47 reduced or exited (28 trimmed, 19 sold completely) — a 63% buyer ratio, indicating clear institutional accumulation. This marks 4 consecutive quarters of net institutional buying — a persistent conviction signal. 20% of total institutional value in OVID is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +27 funds (more new holders than closures). Total institutional holders: 129.

Hedge Fund Ownership: OVID

How many hedge funds hold OVID — quarterly history vs. share price
Quarterly hedge fund ownership of OVID vs. share price

Market Analysis: OVID

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: OVID

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

10 top-rated funds 0 high-conviction
Consensus
4.5
/ 10
breadth
×
Elite
1.5
/ 10
conviction
Hedge Fund Positioning: OVID
128 + Investors

Track Smart Money conviction in OVID. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 128 102 25.49%
13F Shares 147M 106M 39.4%
Total Value $396M $234M 69.15%
New Positions 46 28 +18
Increased Positions 31 33 -2
Closed Positions 19 11 +8
Reduced Positions 29 20 +9
Total Calls 2 4 -50.0%
Total Puts 2 2 -
PUT/CALL Ratio 1.0 0.5 Neutral

Statistics: OVID

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

128 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in OVID. Verified SEC 13F-HR filings.

QUARTER:
Top 25 OVID holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Propel Bio Management, LLC 1.57% 1,115,538 $3.0M
2 Ally Bridge Group (NY) LLC 1.49% 624,561 $1.7M
3 Affinity Asset Advisors, LLC 1.23% 10,144,562 $27.3M
4 Stempoint Capital LP 1.12% 2,417,283 $6.5M
5 Rosalind Advisors, Inc. 1.11% 1,107,994 $3.0M
6 ADAR1 Capital Management, LLC 0.91% 7,417,479 $20.0M
7 Silverarc Capital Management, LLC 0.87% 3,101,129 $8.3M
8 Ikarian Capital, LLC 0.66% 2,269,704 $6.1M
9 Braidwell LP 0.59% 5,919,464 $15.9M
10 Sphera Funds Management LTD. 0.47% 1,353,000 $3.6M
11 Sio Capital Management, LLC 0.45% 1,005,334 $2.7M
12 Eventide Asset Management, LLC 0.42% 11,812,241 $31.8M
13 Saturn V Capital Management LP 0.26% 663,060 $1.8M
14 Ra Capital Management, L.P. 0.25% 10,500,968 $28.2M
15 Velan Capital Investment Management LP 0.21% 130,000 $350K
16 Spark Investment Management LLC 0.17% 31,800 $86K
17 TLS Advisors LLC 0.15% 18,858 $51K
18 Verdad Advisers, LP 0.09% 35,549 $96K
19 Informed Momentum Co LLC 0.06% 259,631 $698K
20 Atom Investors LP 0.06% 251,836 $677K
21 Parkman Healthcare Partners LLC 0.05% 197,947 $532K
22 Orbimed Advisors LLC 0.04% 747,000 $2.0M
23 Stonepine Capital Management, LLC 0.03% 21,300 $57K
24 Boothbay Fund Management, LLC 0.03% 737,758 $2.0M
25 Adage Capital Partners GP, L.L.C. 0.02% 6,163,781 $16.6M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Ovid Therapeutics Inc (OVID)

What does the Smart Money Trend signal show for OVID?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added OVID than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for OVID?

More buyers than sellers — 63% buying: Last quarter: 80 funds were net buyers (46 opened a brand new position + 34 added to an existing one). Only 47 were sellers (28 trimmed + 19 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for OVID holders?

Strong quality — 20% AUM from major funds: 37 of 128 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held OVID?

45% of holders stayed for 2+ years: 58 out of 129 hedge funds have held OVID for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →